Academic Journal
View in EDS
PDF Full Text
HTML Full Text

DNA Methylation of Genes Involved in the HPA Axis in Presence of Suicide Behavior: A Systematic Review

Bibliographic Details
Title: DNA Methylation of Genes Involved in the HPA Axis in Presence of Suicide Behavior: A Systematic Review
Authors: Diana María Dionisio-García, Alma Delia Genis-Mendoza, Thelma Beatriz González-Castro, Carlos Alfonso Tovilla-Zárate, Isela Esther Juarez-Rojop, María Lilia López-Narváez, Yazmín Hernández-Díaz, Humberto Nicolini, Viridiana Olvera-Hernández
Source: Brain Sciences, Vol 13, Iss 4, p 584 (2023)
Publisher Information: MDPI AG, 2023.
Publication Year: 2023
Collection: LCC:Neurosciences. Biological psychiatry. Neuropsychiatry
Subject Terms: DNA methylation, HPA axis, epigenetic, suicide behavior, stress, Neurosciences. Biological psychiatry. Neuropsychiatry, RC321-571
More Details: DNA methylation in genes of the hypothalamic–pituitary–adrenal (HPA) axis has been associated with suicide behavior. Through a systematic review, we aimed to evaluate DNA methylation levels of the genes involved in the HPA pathway and their association with suicide behavior. A search of articles was performed using PubMed and Science Direct, EBSCO. The terms included were “DNA methylation”, “suicide”, “epigenetics”, “HPA axis” and “suicide behavior”. This systematic review was performed by the Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA) statement. Six studies comprising 743 cases and 761 controls were included in this systematic review. The studies included individuals with suicide ideation, suicide attempts or completed suicide and childhood trauma, post-traumatic stress disorder (PTSD), or depression. One study reported hypermethylation in GR in childhood trauma, while two studies found hypermethylation of NR3C1 in childhood trauma and major depressive disorder (MDD). Only one study reported hypermethylation in BNDF in people with MDD. FKBP5 was found to be hypermethylated in people with MDD. Another study reported hypermethylation in CRHBP. SKA2 was reported to be hypermethylated in one study and another study found hypomethylated both in populations with PTSD. CRHR1 was found to be hypermethylated in people with MDD, and the last study found hypomethylation in CRH. Our result showed that patients with suicidal behavior showed a DNA methylation state of genes of the HPA axis in association with psychiatric comorbidity and with adverse events. Genes of the HPA axis could play a role in suicidal behavior associated with adverse events and pathologies. As a result, DNA methylation levels, proteins, and genes involved in the HPA axis could be considered for the search for biomarkers for the prevention of suicidal behavior in future studies.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2076-3425
Relation: https://www.mdpi.com/2076-3425/13/4/584; https://doaj.org/toc/2076-3425
DOI: 10.3390/brainsci13040584
Access URL: https://doaj.org/article/1c7294124ab2461bac6c1e812f022d12
Accession Number: edsdoj.1c7294124ab2461bac6c1e812f022d12
Database: Directory of Open Access Journals
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
    Url: https://content.ebscohost.com/cds/retrieve?content=AQICAHjPtM4BHU3ZchRwgzYmadcigk49r9CVlbU7V5F6lgH7WwErzcmkCJwOYDcsh06X0P__AAAA4jCB3wYJKoZIhvcNAQcGoIHRMIHOAgEAMIHIBgkqhkiG9w0BBwEwHgYJYIZIAWUDBAEuMBEEDLxUpMnKvEljmxy6gQIBEICBmlfANDN7FQNzE4BadEFR_4SvsCWZVyCk6FmQYz1rq_RF4soSdu7UwWOEj6HNSwQ1uNexHfvGVDHOTCWtXqERX7R6IKrSWCVZ83NB9gSFZkW3VURLWJIRC9r1N121mLcsaqtC67ovM1kpXnNqFz-YU5ohhKKGCviu7BzB5ehmED7erWYfRcI0BN25otWJeKL4XvUTzLLxWmRWibc=
Text:
  Availability: 1
  Value: <anid>AN0163369970;[fdu4]01apr.23;2023May02.05:48;v2.2.500</anid> <title id="AN0163369970-1">DNA Methylation of Genes Involved in the HPA Axis in Presence of Suicide Behavior: A Systematic Review </title> <p>DNA methylation in genes of the hypothalamic–pituitary–adrenal (HPA) axis has been associated with suicide behavior. Through a systematic review, we aimed to evaluate DNA methylation levels of the genes involved in the HPA pathway and their association with suicide behavior. A search of articles was performed using PubMed and Science Direct, EBSCO. The terms included were "DNA methylation", "suicide", "epigenetics", "HPA axis" and "suicide behavior". This systematic review was performed by the Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA) statement. Six studies comprising 743 cases and 761 controls were included in this systematic review. The studies included individuals with suicide ideation, suicide attempts or completed suicide and childhood trauma, post-traumatic stress disorder (PTSD), or depression. One study reported hypermethylation in GR in childhood trauma, while two studies found hypermethylation of NR3C1 in childhood trauma and major depressive disorder (MDD). Only one study reported hypermethylation in BNDF in people with MDD. FKBP5 was found to be hypermethylated in people with MDD. Another study reported hypermethylation in CRHBP. SKA2 was reported to be hypermethylated in one study and another study found hypomethylated both in populations with PTSD. CRHR1 was found to be hypermethylated in people with MDD, and the last study found hypomethylation in CRH. Our result showed that patients with suicidal behavior showed a DNA methylation state of genes of the HPA axis in association with psychiatric comorbidity and with adverse events. Genes of the HPA axis could play a role in suicidal behavior associated with adverse events and pathologies. As a result, DNA methylation levels, proteins, and genes involved in the HPA axis could be considered for the search for biomarkers for the prevention of suicidal behavior in future studies.</p> <p>Keywords: DNA methylation; HPA axis; epigenetic; suicide behavior; stress</p> <hd id="AN0163369970-2">1. Introduction</hd> <p>Suicide is a public health problem around the world. According to the World Health Organization (WHO) every year, more than 700,000 individuals die by suicide worldwide [[<reflink idref="bib1" id="ref1">1</reflink>]]. In the United States, 1.20 million suicide attempts were reported in 2020 [[<reflink idref="bib2" id="ref2">2</reflink>]]. The factors involved in suicide development are diverse and complex. Until today, the risk of suicide is associated with clinical, psychological, environmental, and genetic factors. Some studies have found an association between suicidal behavior and alterations in the Hypothalamic-Pituitary–Adrenal axis (HPA), a system that is related to stress and suicidal behavior [[<reflink idref="bib3" id="ref3">3</reflink>]].</p> <p>The literature has found some biological factors associated with suicidal behavior, such as the low function of the serotonergic systems that was present in people who attempted suicide [[<reflink idref="bib1" id="ref4">1</reflink>]], as well as the dopamine system, which is associated with suicide attempt risks in some individuals [[<reflink idref="bib2" id="ref5">2</reflink>]]. Studies also demonstrate that chronic stress has been associated with alterations in the HPA axis and suicidal behavior [[<reflink idref="bib4" id="ref6">4</reflink>], [<reflink idref="bib6" id="ref7">6</reflink>]]. Several studies indicated hypercortisolemia in patients with suicidal behavior [[<reflink idref="bib8" id="ref8">8</reflink>], [<reflink idref="bib10" id="ref9">10</reflink>]], while others reported lower levels of cortisol in response to stress tests [[<reflink idref="bib6" id="ref10">6</reflink>], [<reflink idref="bib11" id="ref11">11</reflink>], [<reflink idref="bib13" id="ref12">13</reflink>]]. No conclusive association has been established between cortisol levels and suicidal behavior, although some studies are searching for epigenetic changes in people with suicidal behavior. The evidence reported that environmental factors causing health problems and epigenetic mechanisms could be associated with the HPA axis and suicidal behavior [[<reflink idref="bib14" id="ref13">14</reflink>]].</p> <p>Epigenetics is the study of modifications that affect gene expression but without changes in DNA sequences [[<reflink idref="bib15" id="ref14">15</reflink>]]. One form of epigenetic change is DNA methylation, which consists of the addition of methyl groups to DNA segments, which leads to reduced gene expression in these DNA regions [[<reflink idref="bib16" id="ref15">16</reflink>]] and prevents the binding of transcriptional activators [[<reflink idref="bib17" id="ref16">17</reflink>]]. DNA methylation sites have been associated with suicide behavior. As an example, people who had a suicide attempt showed lower cortisol concentrations and lower GR or <emph>NR3C1</emph> (α isoform) mRNA [[<reflink idref="bib8" id="ref17">8</reflink>]], which would be linked to <emph>NR3C1</emph> methylation. Moreover, hypomethylation in the <emph>FKBP5</emph> gene has been found in veterans exposed to combat trauma who present post-traumatic stress disorder (PTSD) [[<reflink idref="bib18" id="ref18">18</reflink>]]. This was also observed in people exposed to the holocaust as well as in their offspring [[<reflink idref="bib19" id="ref19">19</reflink>]].</p> <p>Likewise, another study conducted on patients with major depressive disorder (MDD) and suicidal ideation presented hypomethylation of the <emph>FKBP5</emph> gene when compared to patients with MDD and no suicidal ideation [[<reflink idref="bib20" id="ref20">20</reflink>]]. Major depressive disorder is an important disabling mental disorder, and some risk factors that are associated with the development of MDD [[<reflink idref="bib4" id="ref21">4</reflink>]] are a family history of MDD [[<reflink idref="bib5" id="ref22">5</reflink>]], deficits in how individuals process reward [[<reflink idref="bib6" id="ref23">6</reflink>]], substance use disorder [[<reflink idref="bib7" id="ref24">7</reflink>]], sexual abuse [[<reflink idref="bib8" id="ref25">8</reflink>]], social isolation and others [[<reflink idref="bib9" id="ref26">9</reflink>]].</p> <p>In the case of depression, some epigenetic mechanisms could mediate the risk to have depression, not only DNA methylation or microRNAs (miRNAs) and histone modifications. [[<reflink idref="bib10" id="ref27">10</reflink>]]. For example, studies showed altered levels of specific miRNA in the peripheral tissue of patients with MDD [[<reflink idref="bib12" id="ref28">12</reflink>]], and in brain tissue another study found miR-1202 downregulated in the PFC of MDD patients who died by suicide [[<reflink idref="bib13" id="ref29">13</reflink>]]. As for histone modifications, another study found increased global acetylation of histone 3 at lysine 14 (H3K14ac), due to the above in the nucleus accumbens of patients with MDD reported downregulation of HDAC2 [[<reflink idref="bib14" id="ref30">14</reflink>]].</p> <p>Unfortunately, until now there are no conclusive results. Therefore, the roles of the genes that are involved in the HPA axis and suicidal behavior need to be elucidated.</p> <hd id="AN0163369970-3">Aims to Clarify</hd> <p>Additionally, we also aimed to determine if the DNA methylation levels of genes that participate in HPA axis activation could be associated with an increased risk of suicide behavior.</p> <hd id="AN0163369970-4">2. Materials and Methods</hd> <p></p> <hd id="AN0163369970-5">2.1. Search Strategy</hd> <p>A search of relevant studies that investigated the association between DNA methylation levels of genes involved in HPA axis activation and suicidal behavior was performed. The search was conducted up to April 2022 using a predetermined protocol that follows the <emph>Preferred Reporting Items for Systematic Review and Meta-Analyses</emph> (PRISMA) statement. This study was registered with the International Prospective Register of Systematic Reviews (PROSPERO) (registration number 348748).</p> <p>The systematic search included articles that published between 2009 and 2018. This search was performed using three electronic databases (PubMed, Science Direct, and EBSCO). Two authors (DMD-G and TBG-C) independently identified records and extracted data; in case of disagreement, a third researcher intervened and decided. Several combinate questions of terms were used for the search: "methylation and suicide", "methylation and stress", "epigenetics and suicide", "epigenetic and HPA axis", "methylation and suicide behavior", "epigenetic and suicide behavior", "methylation and cortisol", "epigenetic and cortisol". These words were combined in different ways to retrieve the summaries. All the genes that were included had to codify a protein that participated in HPA axis activation. (Figure 1).</p> <hd id="AN0163369970-6">2.2. Inclusion Criteria and Data Extraction</hd> <p>To select suitable studies, the inclusion criteria were (<reflink idref="bib1" id="ref31">1</reflink>) original article, (<reflink idref="bib2" id="ref32">2</reflink>) association studies of suicide and methylation, (<reflink idref="bib3" id="ref33">3</reflink>) studies published in English, and (<reflink idref="bib4" id="ref34">4</reflink>) studies published in peer reviewed journals. From each included article, we retrieved authors, year of publication, country of origin, type of suicide behavior, study design, method of gene expression analysis, methylation measuring method, sample, diagnostics of cases and controls, number of cases and controls, sociodemographic characteristics, genes studied, and main findings.</p> <hd id="AN0163369970-7">2.3. Exclusion Criteria</hd> <p>The exclusion criteria were duplicated publications, studies of cases only or case reports, and papers that did not have enough data available.</p> <hd id="AN0163369970-8">2.4. Quality Assessment of Primary Studies</hd> <p>The quality of the studies was evaluated by the Newcastle–Ottawa scale (NOS). This international scale includes three criteria: (<reflink idref="bib1" id="ref35">1</reflink>) Selection of the studies, (<reflink idref="bib2" id="ref36">2</reflink>) comparability, and (<reflink idref="bib3" id="ref37">3</reflink>) outcomes. The scores range from 0 to 9; scores 7–9 for high quality, scores 4–6 for moderate quality and 0–3 for poor quality.</p> <hd id="AN0163369970-9">2.5. Data synthesis</hd> <p>The information extracted from the studies was organized in tables. The phenotypes included in this systematic review were suicide ideation, suicide attempts, and death by suicide.</p> <hd id="AN0163369970-10">3. Results</hd> <p></p> <hd id="AN0163369970-11">3.1. Characteristics of Eligible Studies</hd> <p>A total of 15 articles of interest were reviewed for title and abstract; of those, 9 articles were excluded, because they did not evaluate suicide behavior. Finally, we included six studies in this systematic review (Figure 2). Two studies used brain tissue to measure DNA methylation levels in individuals who died by suicide [[<reflink idref="bib21" id="ref38">21</reflink>]] and four studies used blood to measure DNA methylation in individuals with suicidal ideation and suicide attempts [[<reflink idref="bib20" id="ref39">20</reflink>], [<reflink idref="bib23" id="ref40">23</reflink>], [<reflink idref="bib25" id="ref41">25</reflink>]].</p> <hd id="AN0163369970-12">3.2. Characteristics of the Studies</hd> <p>The studies included in this systematic review were published between 2009 and 2018. The sample included cases of individuals with suicidal behavior and healthy controls. The number of cases in each study ranged from 14 to 706 individuals, and the number of controls ranged from 20 to 759. All the studies evaluated males and females. Most of the studies were conducted in United States of America (USA) (<emph>n</emph> = 3, 50%) [[<reflink idref="bib20" id="ref42">20</reflink>], [<reflink idref="bib23" id="ref43">23</reflink>], [<reflink idref="bib25" id="ref44">25</reflink>]], followed by Canada (<emph>n</emph> = 2, 33.33%) [[<reflink idref="bib21" id="ref45">21</reflink>]] and Sweden (<emph>n</emph> = 1, 16.6%) [[<reflink idref="bib24" id="ref46">24</reflink>]]. One study used individuals from the Grady Trauma Project and Johns Hopkins Center for Prevention Research Study [[<reflink idref="bib25" id="ref47">25</reflink>]]. Table 1 shows the characteristics of the studies included. According to the NOS score, the quality of the studies ranged between 7 and 9. See Table 1.</p> <p>Two studies [[<reflink idref="bib21" id="ref48">21</reflink>]] explored the methylation levels using cerebral tissue [[<reflink idref="bib21" id="ref49">21</reflink>]] and the hippocampus and Broadman area 24 [[<reflink idref="bib22" id="ref50">22</reflink>]]. Two studies used peripheral blood [[<reflink idref="bib20" id="ref51">20</reflink>], [<reflink idref="bib23" id="ref52">23</reflink>]], one used whole blood [[<reflink idref="bib24" id="ref53">24</reflink>]] and one used whole blood and saliva [[<reflink idref="bib25" id="ref54">25</reflink>]]. The CPG site with changes in epigenetics was <emph>SKA2</emph> CpG 13989295 [[<reflink idref="bib23" id="ref55">23</reflink>], [<reflink idref="bib25" id="ref56">25</reflink>]] <emph>GR</emph> Glucocorticoid receptor CpG6, CpG8, CpG11 [[<reflink idref="bib21" id="ref57">21</reflink>]], <emph>N3CR1</emph> CpG30, CpG32 [[<reflink idref="bib22" id="ref58">22</reflink>]], <emph>CRH</emph> Corticotropin-Releasing-Hormone CpG19035496 and CpG23409074 [[<reflink idref="bib24" id="ref59">24</reflink>]]. See Table 2.</p> <p>A summary and comparative table of the methylation state of genes included in the present study of the influence in the activation of the HPA axis and reported in childhood trauma, post-traumatic stress disorder (PTSD), depression, and psychiatric risk are shown in the Table 3.</p> <p>Labonte B. et al., 2012 [[<reflink idref="bib21" id="ref60">21</reflink>]] analyzed the first eight coding exons of human glucocorticoid receptor (HGR). The exon named <emph>HGRB1</emph> (CPG6 site) showed hypermethylation in individuals who were abuse victims and died by suicide when compared to healthy individuals for (<emph>p</emph> < 0.005) and CPG8 site (<emph>p</emph> < 0.05). By contrast, hypomethylation was observed for CpG11 site (<emph>p</emph> < 0.005). Patients with childhood trauma and death by suicide showed hypermethylation in the CpG8, CpG9 site when compared to those without childhood trauma (<emph>p</emph> < 0.005) and in CpG12 site of the <emph>HGRC1</emph> exon. By contrast, the CpG13 site was significantly hypomethylated. The findings in terms of the HGR1H exon were hypomethylation in individuals in abuse victims dead by suicide group compared to the non-abused dead by suicide and control groups for the CpG2 site, CpG5 site and CpG10 site (non-abused dead by suicide: <emph>p</emph> < 0.01, healthy controls: <emph>p</emph> < 0.05). With regard to the CpG1 site, a significant lower methylation was observed in the abused dead by suicide group (<emph>p</emph> < 0.05) compared to the controls without any significant difference between the abused dead by suicide and non-abused dead by suicide groups. Finally, a lower methylation at the CpG3 (<emph>p</emph> < 0.005), CpG7 (<emph>p</emph> < 0.05), CpG8 (<emph>p</emph> < 0.05), and CpG12 sites (<emph>p</emph> < 0.01) was observed in the abused dead by suicide group compared to the non-abused dead by suicide group, whereas no significant difference was found between the abused dead by suicide group and the healthy controls.</p> <p>Other study conducted by McGowan [[<reflink idref="bib22" id="ref61">22</reflink>]] used the same overlapping cohort with Labonte, with a similar clinical group from the same bank brain in Canada. This compared the methylation of the <emph>NR3C1</emph> gene in the postmortem hippocampus obtained from three groups: first, individuals who died by suicide and had a history of childhood trauma; second, individuals who died by suicide without a history of childhood trauma; and third, the individuals who died by any other cause. The analysis of methylation of the F exon showed no statistical differences between groups. Nonetheless, the analysis of the 1F exon showed hypermethylation in individuals who died by suicide and had history of childhood trauma when compared to non-abused individuals who died by suicide.</p> <p>One study analyzed the methylation of the <emph>SKA2</emph> gene in patients with post-traumatic stress disorder [[<reflink idref="bib25" id="ref62">25</reflink>]]. They found a significant interaction between the scores of the Child Trauma Questionnaire (CTQ) and <emph>SKA2</emph> hypermethylation, after adjusting age, sex, race, and lifetime history of substance abuse (β-value 0.100, <emph>p</emph> = 0.037). Furthermore, <emph>SKA2</emph> DNA methylation interacted with the scores of CTQ to predict a lifetime suicide attempt of 0.76 and 0.73 (95% confidence interval (CI): 0.6–0.92, <emph>p</emph> = 0.003, and CI: 0.65–0.78, <emph>p</emph> = 0.0001). The interaction between trauma and methylation of <emph>SKA2</emph> DNA was stronger when trauma resulted from emotional abuse than from physical or sexual abuse (β-value 0.0036, <emph>p</emph> = 0.01).</p> <p>A study in veterans analyzed the methylation levels in <emph>SKA2</emph> DNA [[<reflink idref="bib23" id="ref63">23</reflink>]]. They used the PTSD scale to assess the frequency and severity of the 17 symptoms of PTSD reported in the DSM-IV. The regression analysis demonstrated a significant association between the <emph>SKA2</emph> hypomethylation and current suicidal thoughts and behaviors (β = 0.27, <emph>p</emph> = 0.014); however, the <emph>SKA2</emph> methylation was not significantly associated with current or lifetime PTSD severity scores (|βs| < 0.05, <emph>p</emph> ≥ 0.66).</p> <p>Roy B. et al., 2017 found that <emph>BNDF, FKBP5, CRHBP,</emph> and <emph>NR3C1</emph> gene promoters were hypermethylated in individuals with major depression disorder with and without suicidal ideation compared to the controls [[<reflink idref="bib20" id="ref64">20</reflink>]]. The results showed an enrichment of CpG islands in the promoter regions of stress related genes and were significantly different between MDD-suicidal ideation and the healthy controls: <emph>BNDF</emph> (<emph>p</emph> = 0.039), <emph>FKBP5</emph> (<emph>p</emph> = 0.035), <emph>CRHBP</emph> (<emph>p</emph> = 0.039) and <emph>NR3C1</emph> (<emph>p</emph> = 0.025), but not <emph>CRHR1</emph> (<emph>p</emph> = 0.37); between MDD-non-suicidal ideation and the healthy controls, significant differences were noted in: <emph>BNDF</emph> (<emph>p</emph> = 0.31), <emph>FKBP5</emph> (<emph>p</emph> = 0.13), <emph>CRHBP</emph> (<emph>p</emph> = 0.72), <emph>CRHR1</emph> (<emph>p</emph> = 0.96), and <emph>NR3C1</emph> (<emph>p</emph> = 0.15), and this is associated with the decreased expression of BNDF, FKBPF5 (variants 1,2 y 3) NR3C1 genes in these patients.</p> <p>Finally, Jokinen et al. [[<reflink idref="bib24" id="ref65">24</reflink>]] stratified the sample into high-risk and low-risk groups based on the severity of the suicide attempt and identified the hypothalamic–pituitary– adrenal axis coupled CpG-sites showing hypomethylation shifts linked to the severity of the suicide attempt. Two <emph>CRH</emph>-associated CpG sites were significantly hypomethylated in patients with severe suicide attempts cg19035496 (<emph>p</emph> = 0.049) and cg23409074 (<emph>p</emph> = 0.016).</p> <hd id="AN0163369970-13">4. Discussion</hd> <p>Our systematic review analyzed the DNA methylation in genes related to the HPA axis in suicide attempts, suicidal ideation, and deaths by suicide in association with childhood trauma, PTSD, major depressive disorder, and psychiatric risk. The results of these articles demonstrated epigenetic changes in genes related to the HPA axis and were associated with suicide behavior. Suicide is a worldwide health problem. Globally, it is the fourth leading cause of death in people aged 15–29 years [[<reflink idref="bib2" id="ref66">2</reflink>]]. The factors associated with the development of suicidal behavior are diverse and complex; in the last years, the HPA axis alterations have been highly related to suicide [[<reflink idref="bib5" id="ref67">5</reflink>], [<reflink idref="bib26" id="ref68">26</reflink>]]. This axis responds to situations that generate stress and alter homeostasis [[<reflink idref="bib28" id="ref69">28</reflink>]].</p> <p>In this review, we found that some genes that are part of the HPA axis activation showed epigenetic changes in people with suicidal behavior [[<reflink idref="bib29" id="ref70">29</reflink>]]. In the case of the <emph>CRH</emph> gene, it expresses the hormone that helps establish the initial response of the HPA axis to a stressful event [[<reflink idref="bib31" id="ref71">31</reflink>]]. This corticotropin-releasing hormone receptor has been observed hypomethylated and its expression increased in individuals who attempted suicide [[<reflink idref="bib24" id="ref72">24</reflink>]]. Moreover, elevated <emph>CRH</emph> levels have been found in extra hypothalamic brain regions of individuals with depression who died by suicide [[<reflink idref="bib32" id="ref73">32</reflink>]]. In the case of the <emph>FKBP5</emph> gene, which encodes the FKBP51 protein (cis-trans prolyl isomerase), its most important function is to influence binding affinity in glucocorticoid receptor signaling [[<reflink idref="bib33" id="ref74">33</reflink>]], which is hypomethylated in people who attempted suicide and also in patients with depression and suicidal ideation [[<reflink idref="bib20" id="ref75">20</reflink>], [<reflink idref="bib24" id="ref76">24</reflink>]]. Joined studies found that alterations in methylated levels of <emph>CRH</emph> were associated with post-traumatic stress disorder, bipolar disorder, suicide attempts, and major depressive disorder in HIV patients [[<reflink idref="bib34" id="ref77">34</reflink>]]. On the other hand, the <emph>NR3C1</emph> expresses the cortisol receptor and mediates glucocorticoid actions, and it also functions as a hormone-dependent transcription factor that regulates the expression of glucocorticoid-responsive genes [[<reflink idref="bib35" id="ref78">35</reflink>]], which is hypermethylated in people with suicide ideation and depression [[<reflink idref="bib20" id="ref79">20</reflink>]], as well as the <emph>CRHBP</emph> gene, which codifies the corticotrophin-releasing factor-binding protein, regulates HPA axis function and stimulates synthesis and secretion of proopiomelanocortin derived peptides [[<reflink idref="bib36" id="ref80">36</reflink>]]. This gene was found to be hypermethylated in patients who attempted suicide and patients with major depressive disorder with and without suicidal ideation [[<reflink idref="bib20" id="ref81">20</reflink>], [<reflink idref="bib24" id="ref82">24</reflink>]]. Last, the <emph>SKA2</emph> gene encodes a protein involved in metaphase plate maintenance and spindle checkpoint silencing during mitosis [[<reflink idref="bib37" id="ref83">37</reflink>]] and has been implicated in enabling glucocorticoid receptor nuclear transactivation [[<reflink idref="bib38" id="ref84">38</reflink>]]. A decreased expression of the <emph>SKA2</emph> gene has been observed in the prefrontal cortex of people who died by suicide [[<reflink idref="bib39" id="ref85">39</reflink>]]. In addition, hypermethylation of the <emph>SKA2</emph> gene has been observed in patients with post-traumatic stress disorder and suicidal behavior [[<reflink idref="bib23" id="ref86">23</reflink>], [<reflink idref="bib25" id="ref87">25</reflink>]].</p> <p>The findings of this systematic review suggest that genes of the HPA stress response pathway are significantly associated with suicidal behavior [[<reflink idref="bib40" id="ref88">40</reflink>]]. As the DNA methylation of these genes is altered, the genes may be influencing a dysregulation of HPA axis activity as measured by altered cortisol levels [[<reflink idref="bib6" id="ref89">6</reflink>], [<reflink idref="bib41" id="ref90">41</reflink>]]. Interestingly, some GWAS studies have reported a significant association between HPA axis genes such as <emph>CRHR1, CRHR2, FKBP5, CRHBP, NR3C1, AVPR1B,</emph> and suicidal behavior [[<reflink idref="bib42" id="ref91">42</reflink>]]. Overall, this evidence suggests a role of the HPA axis genes and suicide behavior. Whether the HPA axis response is moderated or altered, ultimately it influences the suppression of cortisol in its response to stress. Therefore, for this pathway we also need to search and identify probable biological markers that will be capable of identifying the risk of suicide in our population, serving as prevention for the population.</p> <p>We recognize that there are previous reviews that identified the alterations in epigenetics with the HPA axis associated with suicidality, highlighting the importance of this axis's findings and suicide [[<reflink idref="bib44" id="ref92">44</reflink>]] or genetic modifications related to defective regulation of the HPA axis in suicidal behavior [[<reflink idref="bib45" id="ref93">45</reflink>]]. However, ours is the first study to aggregate reports of genes involved in the HPA pathway.</p> <p>The most outstanding findings were in suicide completers with childhood trauma, <emph>NR3C1</emph> gene reported hypermethylation, and also in the case of suicidal ideation with MDD, <emph>NR3C1, BNDF, FKBP5, CRHBP,</emph> and <emph>CRHR1</emph> found in hypermethylation. Likewise, <emph>SKA2</emph> genes studied in PTSD and suicide attempters were hypermethylated. Furthermore, in suicide attempters and psychiatric risk the reported CRH gene was hypomethylated. At the same, in patients with suicidal thoughts and PTSD, the <emph>SKA2</emph> was found to be hypomethylated. Based on these findings, it might be suggested that DNA methylation depends on suicidal behavior and pathology.</p> <p>Our study has some limitations. First, the studies included broad diverse pathologies: childhood trauma, post-traumatic stress disorder, and depression. Perhaps, it could be a limitation, but pathologies that are due to childhood events of traumas are associated with epigenetic changes [[<reflink idref="bib47" id="ref94">47</reflink>]]. Therefore, the studies used different inclusion and exclusion criteria for their participants. Second, each study evaluated different behaviors: death by suicide, suicide behavior, suicide ideation, and suicide attempts. Finally, some studies measured DNA methylation levels in differences tissues.</p> <p>In conclusion, in this systematic review we found that the DNA methylation state of some genes essential for the activation of the HPA axis is altered. This state of DNA methylation is related to suicide behavior, suicide attempts, or suicide risk in patients with different psychiatric comorbidities and with adverse events. As a result, the HPA axis could be considered as a possible field to search biological markers that help prevent suicide behavior. Because genes that have changes in their methylation levels are involved in the activation of the HPA axis and in the creation of the hormone cortisol, they could share this common pathway.</p> <hd id="AN0163369970-14">Figures and Tables</hd> <p>Graph: Figure 1 PRISMA flow chart that includes all the processes of choosing articles.</p> <p>Graph: Figure 2 Risk of bias summary: a review of authors' judgments about risk of bias item for each included study [[<reflink idref="bib20" id="ref95">20</reflink>], [<reflink idref="bib22" id="ref96">22</reflink>], [<reflink idref="bib24" id="ref97">24</reflink>]].</p> <p>Table 1 Characteristics of the included publications that evaluated methylation of HPA genes expression (mRNA) in the pathogenesis of suicide behavior.</p> <p> <ephtml> <table><thead><tr><th colspan="9" align="center" style="border-top:solid thin;border-bottom:solid thin">Brain Samples</th></tr><tr><th rowspan="2" align="center" style="border-bottom:solid thin">Author and Year</th><th rowspan="2" align="center" style="border-bottom:solid thin">Origin</th><th rowspan="2" align="center" style="border-bottom:solid thin">Genes</th><th align="center" style="border-bottom:solid thin">Diagnostics</th><th colspan="2" align="center" style="border-bottom:solid thin">Cases</th><th colspan="2" align="center" style="border-bottom:solid thin">Controls</th><th rowspan="2" align="center" style="border-bottom:solid thin">NOS</th></tr><tr><th align="center" style="border-bottom:solid thin">Cases/<break />Controls</th><th align="center" style="border-bottom:solid thin">Median Age</th><th align="center" style="border-bottom:solid thin">Male/<break />Female</th><th align="center" style="border-bottom:solid thin">Median Age</th><th align="center" style="border-bottom:solid thin">Male/<break />Female</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin">Labonte B. 2012 [<xref ref-type="bibr" rid="bibr21">21</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin">French-<break />Canadian <break />Caucasian</td><td align="center" valign="middle" style="border-bottom:solid thin">GR</td><td align="center" valign="middle" style="border-bottom:solid thin">ELS/<break />non-psychiatric</td><td align="center" valign="middle" style="border-bottom:solid thin">39.05 ± 2.4</td><td align="center" valign="middle" style="border-bottom:solid thin">42/0</td><td align="center" valign="middle" style="border-bottom:solid thin">39.8 ± 3.9</td><td align="center" valign="middle" style="border-bottom:solid thin">14/<break />0</td><td align="center" valign="middle" style="border-bottom:solid thin">9</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin">McGowan PO, 2009 [<xref ref-type="bibr" rid="bibr22">22</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin">French-Canadian</td><td align="center" valign="middle" style="border-bottom:solid thin">N3CR1</td><td align="center" valign="middle" style="border-bottom:solid thin">Childhood trauma/<break />non-psychiatric</td><td align="center" valign="middle" style="border-bottom:solid thin">34.2 ± 10/33.8 ± 11</td><td align="center" valign="middle" style="border-bottom:solid thin">24/0</td><td align="center" valign="middle" style="border-bottom:solid thin">35.8 ± 12</td><td align="center" valign="middle" style="border-bottom:solid thin">12/<break />0</td><td align="center" valign="middle" style="border-bottom:solid thin">9</td></tr><tr><td colspan="9" align="center" valign="middle" style="border-bottom:solid thin">Blood samples</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin">Sadeh N. 2016 [<xref ref-type="bibr" rid="bibr23">23</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin">White, non-Hispanic</td><td align="center" valign="middle" style="border-bottom:solid thin">SKA2</td><td align="center" valign="middle" style="border-bottom:solid thin">PTSD</td><td align="center" valign="middle" style="border-bottom:solid thin">52.4 ± 10.7</td><td align="center" valign="middle" style="border-bottom:solid thin">302/104</td><td align="center" valign="middle" style="border-bottom:solid thin" /><td align="center" valign="middle" style="border-bottom:solid thin" /><td align="center" valign="middle" style="border-bottom:solid thin">9</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin">Roy B, 2017 [<xref ref-type="bibr" rid="bibr20">20</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin">Caucasian/African American</td><td align="center" valign="middle" style="border-bottom:solid thin">BNDF<break />NR3C1<break />FKBP5<break />CRHBP<break />CRHR1</td><td align="center" valign="middle" style="border-bottom:solid thin">MDD with suicidal ideation/<break />Healthy controls<break />MDD without suicidal ideation</td><td align="center" valign="middle" style="border-bottom:solid thin">42.90 ± 2.99</td><td align="center" valign="middle" style="border-bottom:solid thin">6/8</td><td align="center" valign="middle" style="border-bottom:solid thin">-</td><td align="center" valign="middle" style="border-bottom:solid thin">6/<break />14</td><td align="center" valign="middle" style="border-bottom:solid thin">9</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin">Kaminsky Z, 2015 [<xref ref-type="bibr" rid="bibr25">25</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin">African American</td><td align="center" valign="middle" style="border-bottom:solid thin">SKA2</td><td align="center" valign="middle" style="border-bottom:solid thin">PTSD with current suicidal ideation<break />PTSD with lifetime suicide attempts/<break />Healthy controls</td><td align="center" valign="middle" style="border-bottom:solid thin">52.4</td><td align="center" valign="middle" style="border-bottom:solid thin">-<break />-</td><td align="center" valign="middle" style="border-bottom:solid thin">-</td><td align="center" valign="middle" style="border-bottom:solid thin">-<break />-</td><td align="center" valign="middle" style="border-bottom:solid thin">7</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin">Jokinen J. 2018 [<xref ref-type="bibr" rid="bibr24">24</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" /><td align="center" valign="middle" style="border-bottom:solid thin">CRH<break />CRHBP<break />CRHR1<break />FKBP5<break />NR3C1</td><td align="center" valign="middle" style="border-bottom:solid thin">Suicide attempts/<break />Healthy controls</td><td align="center" valign="middle" style="border-bottom:solid thin">35.16 ± 12.3</td><td align="center" valign="middle" style="border-bottom:solid thin">16/15</td><td align="center" valign="middle" style="border-bottom:solid thin">33.6 ± 12.2</td><td align="center" valign="middle" style="border-bottom:solid thin">12/<break />45</td><td align="center" valign="middle" style="border-bottom:solid thin">8</td></tr></tbody></table> </ephtml> GR: Glucocorticoid Receptor; N3CR1: SKA2: Spindle and Kinetochore Associated Complex Subunit 2; BNDF: Brain-Derived Neurotrophic Factor; FKBP5: FKBP Prolyl Isomerase 5; CRHBP: Corticotropin-Releasing Hormone Binding Protein; CRHR1: Corticotropin-Releasing Hormone Receptor 1; CRH: Corticotropin-Releasing Hormone; CRHBP: Corticotropin-Releasing Hormone Binding Protein; ELS: Early-Life Stress; MDD: Major Depressive Disorder.</p> <p>Table 2 Characteristics of the studies included in the systematic review.</p> <p> <ephtml> <table><thead><tr><th rowspan="2" align="center" style="border-top:solid thin;border-bottom:solid thin">Author and Year</th><th rowspan="2" align="center" style="border-top:solid thin;border-bottom:solid thin">Country</th><th align="center" style="border-top:solid thin;border-bottom:solid thin">Population Data (N)</th><th rowspan="2" align="center" style="border-top:solid thin;border-bottom:solid thin">Main Outcomes</th></tr><tr><th align="center" style="border-bottom:solid thin">Cases/Controls</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin">Labonte B, 2012 [<xref ref-type="bibr" rid="bibr21">21</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin">Canada</td><td align="center" valign="middle" style="border-bottom:solid thin">42/14</td><td align="center" valign="middle" style="border-bottom:solid thin">Hypermethylation of the GR gene in the hippocampus<break />CPG6 (SA: <italic>p</italic> < 0.05; SNA: <italic>p</italic> < 0.005), CPG8 (SA: <italic>p</italic> < 0.05, SNA: <italic>p</italic> < 0.05), CPG11 (SA: <italic>p</italic> < 0.005; SNA: <italic>p</italic> < 0.005).</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin">McGowan PO, 2009 [<xref ref-type="bibr" rid="bibr22">22</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin">Canada</td><td align="center" valign="middle" style="border-bottom:solid thin">24/12</td><td align="center" valign="middle" style="border-bottom:solid thin">RNAm transcripts bearing the glucocorticoid receptor 1 slice variant and increased cytosine Methylation NR3C1 promotes.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin">Roy B, 2017 [<xref ref-type="bibr" rid="bibr20">20</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin">United States of America</td><td align="center" valign="middle" style="border-bottom:solid thin">14/20</td><td align="center" valign="middle" style="border-bottom:solid thin">Hypermethylation in MDD patients with and without suicidal ideation gene promoters BNDF, NR3C1, FKBP5, CRHBP.<break />CPG30 (<italic>p</italic> < 0.001), CPG32 (<italic>p</italic> < 0.001) deaths by suicide with no history of childhood trauma and controls.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin">Kaminsky Z, 2015 [<xref ref-type="bibr" rid="bibr25">25</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin">United States of America</td><td align="center" valign="middle" style="border-bottom:solid thin">67 CSI<break />/99 LSAC/<break />337/<break />321</td><td align="center" valign="middle" style="border-bottom:solid thin">SKA2 methylation levels also predicted higher rates of current suicidal thoughts and behaviors.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin">Jokinen J, 2018 [<xref ref-type="bibr" rid="bibr24">24</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin">Sweden</td><td align="center" valign="middle" style="border-bottom:solid thin">31/<break />57</td><td align="center" valign="middle" style="border-bottom:solid thin">Hypomethylation Two CpG CRH cg19035496 and cg23409074, in suicide attempters and hypermethylated cg19035496 high general psychiatric risk score.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin">Sadeh N, 2016 [<xref ref-type="bibr" rid="bibr23">23</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin">United States of America</td><td align="center" valign="middle" style="border-bottom:solid thin">466</td><td align="center" valign="middle" style="border-bottom:solid thin">Methylation at the CpG locus cg13989295 was associated with higher rates of suicidal thoughts and behaviors.</td></tr></tbody></table> </ephtml> CSI: current suicidal ideators; LSAC: lifetime suicide attempt cases, #CpG: site when cytosine and guanine appear consecutively on the same strand of nucleic acid. SA: Suicide Attempted. MDD: Major Depressive Disorder.</p> <p>Table 3 The methylation state of genes that influence the activation of the HPA axis and reported in ELS, PTSD, MDD, and psychiatric risk.</p> <p> <ephtml> <table><thead><tr><th rowspan="2" align="center" style="border-top:solid thin;border-bottom:solid thin">Gene</th><th colspan="3" align="center" style="border-top:solid thin;border-bottom:solid thin">Childhood Trauma</th><th colspan="3" align="center" style="border-top:solid thin;border-bottom:solid thin">Post-Traumatic Stress Disorder</th><th colspan="3" align="center" style="border-top:solid thin;border-bottom:solid thin">Major Depressive Disorder</th><th colspan="3" align="center" style="border-top:solid thin;border-bottom:solid thin">General Psychiatric Risk</th><th align="center" style="border-top:solid thin;border-bottom:solid thin">References</th></tr><tr><th align="center" style="border-bottom:solid thin">N</th><th align="center" style="border-bottom:solid thin">Hypo</th><th align="center" style="border-bottom:solid thin">Hyper</th><th align="center" style="border-bottom:solid thin">N</th><th align="center" style="border-bottom:solid thin">Hypo</th><th align="center" style="border-bottom:solid thin">Hyper</th><th align="center" style="border-bottom:solid thin">N</th><th align="center" style="border-bottom:solid thin">Hypo</th><th align="center" style="border-bottom:solid thin">Hyper</th><th align="center" style="border-bottom:solid thin">N</th><th align="center" style="border-bottom:solid thin">Hypo</th><th align="center" style="border-bottom:solid thin">Hyper</th><th align="center" style="border-bottom:solid thin" /></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin">GR</td><td align="center" valign="middle" style="border-bottom:solid thin">1</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">1</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">Labonte B, 2012 [<xref ref-type="bibr" rid="bibr21">21</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin">NR3C1</td><td align="center" valign="middle" style="border-bottom:solid thin">1</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">1</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">1</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">1</td><td align="center" valign="middle" style="border-bottom:solid thin">1</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">McGowan PO, 2009 [<xref ref-type="bibr" rid="bibr22">22</xref>]<break />Roy B, 2017 [<xref ref-type="bibr" rid="bibr20">20</xref>]<break />Jokinen J. 2018 [<xref ref-type="bibr" rid="bibr24">24</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin">BNDF</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">1</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">1</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">Roy B, 2017 [<xref ref-type="bibr" rid="bibr20">20</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin">FKBP5</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">1</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">1</td><td align="center" valign="middle" style="border-bottom:solid thin">1</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">Roy B, 2017 [<xref ref-type="bibr" rid="bibr20">20</xref>]<break />Jokinen J. 2018 [<xref ref-type="bibr" rid="bibr24">24</xref>] </td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin">CRHBP</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">1</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">1</td><td align="center" valign="middle" style="border-bottom:solid thin">1</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">Roy B, 2017 [<xref ref-type="bibr" rid="bibr20">20</xref>]<break />Jokinen J. 2018 [<xref ref-type="bibr" rid="bibr24">24</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin">SKA2</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">2</td><td align="center" valign="middle" style="border-bottom:solid thin">1</td><td align="center" valign="middle" style="border-bottom:solid thin">1</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">Kaminsky Z. 2015 [<xref ref-type="bibr" rid="bibr25">25</xref>]<break />Sadeh N. 2016 [<xref ref-type="bibr" rid="bibr23">23</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin">CRHR1</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">1</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">1</td><td align="center" valign="middle" style="border-bottom:solid thin">1</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">Roy B. 2017 [<xref ref-type="bibr" rid="bibr20">20</xref>]<break />Jokinen J. 2018 [<xref ref-type="bibr" rid="bibr24">24</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin">CRHR2</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">1</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">Jokinen J. 2018 [<xref ref-type="bibr" rid="bibr24">24</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin">CRH</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">1</td><td align="center" valign="middle" style="border-bottom:solid thin">1</td><td align="center" valign="middle" style="border-bottom:solid thin">0</td><td align="center" valign="middle" style="border-bottom:solid thin">Jokinen J. 2018 [<xref ref-type="bibr" rid="bibr24">24</xref>]</td></tr></tbody></table> </ephtml> Hypo: hypomethylation; Hyper: hypermethylation.</p> <hd id="AN0163369970-15">Author Contributions</hd> <p>Conceptualization, D.M.D.-G., A.D.G.-M., T.B.G.-C. and C.A.T.-Z.; methodology, D.M.D.-G., T.B.G.-C., A.D.G.-M. and C.A.T.-Z.; software, D.M.D.-G., T.B.G.-C. and C.A.T.-Z.; validation, D.M.D.-G., T.B.G.-C., C.A.T.-Z., I.E.J.-R., M.L.L.-N., Y.H.-D., H.N. and V.O.-H.; formal analysis, D.M.D.-G., A.D.G.-M.,T.B.G.-C. and C.A.T.-Z.; investigation, D.M.D.-G.; resources, A.D.G.-M. and H.N.; data curation, D.M.D.-G. and A.D.G.-M.; writing—original draft preparation, D.M.D.-G., A.D.G.-M., T.B.G.-C. and C.A.T.-Z., writing—review and editing, D.M.D.-G., A.D.G.-M., T.B.G.-C. and C.A.T.-Z.; visualization, D.M.D.-G., A.D.G.-M., T.B.G.-C. and C.A.T.-Z.; supervision, D.M.D.-G., A.D.G.-M., T.B.G.-C. and C.A.T.-Z.; project administration, D.M.D.-G., A.D.G.-M., T.B.G.-C. and C.A.T.-Z.; funding acquisition, A.D.G.-M. and H.N. All authors have read and agreed to the published version of the manuscript.</p> <hd id="AN0163369970-16">Institutional Review Board Statement</hd> <p>Not applicable.</p> <hd id="AN0163369970-17">Informed Consent Statement</hd> <p>Not applicable.</p> <hd id="AN0163369970-18">Data Availability Statement</hd> <p>Not applicable.</p> <hd id="AN0163369970-19">Conflicts of Interest</hd> <p>The authors declare no conflict of interest.</p> <ref id="AN0163369970-20"> <title> Footnotes </title> <blist> <bibl id="bib1" idref="ref1" type="bt">1</bibl> <bibtext> Disclaimer/Publisher's Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</bibtext> </blist> </ref> <ref id="AN0163369970-21"> <title> References </title> <blist> <bibtext> WHO. Suicide Worldwide in 2019: Global Health Estimates 201916June. 2021Available online: https://<ulink href="http://www.who.int/publications/i/item/9789240026643(accessed">www.who.int/publications/i/item/9789240026643(accessed</ulink> on 3 February 2023)</bibtext> </blist> <blist> <bibl id="bib2" idref="ref2" type="bt">2</bibl> <bibtext> WHO. Suicide17June. 2021Available online: https://<ulink href="http://www.who.int/news-room/fact-sheets/detail/suicide(accessed">www.who.int/news-room/fact-sheets/detail/suicide(accessed</ulink> on 20 May 2022)</bibtext> </blist> <blist> <bibl id="bib3" idref="ref3" type="bt">3</bibl> <bibtext> Hernández-Díaz Y., Genis-Mendoza A.D., González-Castro T.B., Tovilla-Zárate C.A., Juárez-Rojop I.E., López-Narváez M.L., Nicolini H. Association and Genetic Expression between Genes Involved in HPA Axis and Suicide Behavior: A Systematic Review. Genes. 2021; 121608. 10.3390/genes12101608. 34681002</bibtext> </blist> <blist> <bibl id="bib4" idref="ref6" type="bt">4</bibl> <bibtext> Lippard E.T.C., Johnston J.A., Blumberg H.P. Neurobiological Risk Factors for Suicide. Am. J. Prev. Med. 2014; 47: S152-S162. 10.1016/j.amepre.2014.06.009. 25145733</bibtext> </blist> <blist> <bibl id="bib5" idref="ref22" type="bt">5</bibl> <bibtext> O'Connor D.B., Gartland N., O'Connor R.C. Stress, cortisol and suicide risk. Int. Rev. Neurobiol. 2020; 152: 101-130. 10.1016/bs.irn.2019.11.006</bibtext> </blist> <blist> <bibl id="bib6" idref="ref7" type="bt">6</bibl> <bibtext> O'Connor D.B., Green J.A., Ferguson E., O'Carroll R.E., O'Connor R.C. Cortisol reactivity and suicidal behavior: Investigating the role of hypothalamic-pituitary-adrenal axis responses to stress in suicide attempters and ideators. Psychoneuroendocrinology. 2017; 75: 183-191. 10.1016/j.psyneuen.2016.10.019</bibtext> </blist> <blist> <bibl id="bib7" idref="ref24" type="bt">7</bibl> <bibtext> Shalev A., Porta G., Biernesser C., Zelazny J., Walker-Payne M., Melhem N., Brent D. Cortisol response to stress as a predictor for suicidal ideation in youth. J. Affect. Disord. 2019; 257: 10-16. 10.1016/j.jad.2019.06.053. 31299399</bibtext> </blist> <blist> <bibl id="bib8" idref="ref8" type="bt">8</bibl> <bibtext> Melhem N.M., Munroe S., Marsland A., Gray K., Brent D., Porta G., Douaihy A., Laudenslager M.L., De Pietro F., Diler R. Blunted HPA axis activity prior to suicide attempt and increased inflammation in attempters. Psychoneuroendocrinology. 2017; 77: 284-294. 10.1016/j.psyneuen.2017.01.001</bibtext> </blist> <blist> <bibl id="bib9" idref="ref26" type="bt">9</bibl> <bibtext> Pfennig A., Kunzel H.E., Kern N., Ising M., Majer M., Fuchs B., Ernst G., Holsboer F., Binder E.B. Hypothalamus-pituitary-adrenal system regulation and suicidal behavior in depression. Biol. Psychiatry. 2005; 57: 336-342. 10.1016/j.biopsych.2004.11.017</bibtext> </blist> <blist> <bibtext> Brunner J., Stalla G.K., Stalla J., Uhr M., Grabner A., Wetter T.C., Bronisch T. Decreased corticotropin-releasing hormone (CRH) concentrations in the cerebrospinal fluid of eucortisolemic suicide attempters. J. Psychiatr. Res. 2001; 35: 1-9. 10.1016/S0022-3956(01)00007-3</bibtext> </blist> <blist> <bibtext> McGirr A. Dysregulation of the sympathetic nervous system, hypothalamic–pituitary–adrenal axis and executive function in individuals at risk for suicide. J. Psychiatry Neurosci. 2010; 35: 399-408. 10.1503/jpn.090121</bibtext> </blist> <blist> <bibtext> McGirr A., Diaconu G., Berlim M.T., Turecki G. Personal and family history of suicidal behaviour is associated with lower peripheral cortisol in depressed outpatients. J. Affect. Disord. 2011; 131: 368-373. 10.1016/j.jad.2010.10.050</bibtext> </blist> <blist> <bibtext> Melhem N.M., Keilp J.G., Porta G., Oquendo M.A., Burke A., Stanley B., Cooper T.B., Mann J.J., Brent D.A. Blunted HPA Axis Activity in Suicide Attempters Compared to those at High Risk for Suicidal Behavior. Neuropsychopharmacology. 2016; 41: 1447-1456. 10.1038/npp.2015.309. 26450815</bibtext> </blist> <blist> <bibtext> Vaiserman A.M., Koliada A.K. Early-life adversity and long-term neurobehavioral outcomes: Epigenome as a bridge?. Hum. Genom. 2017; 11: 34. 10.1186/s40246-017-0129-z. 29246185</bibtext> </blist> <blist> <bibtext> Gayon J. From Mendel to epigenetics: History of genetics. Comptes Rendus Biol. 2016; 339: 225-230. 10.1016/j.crvi.2016.05.009. 27263362</bibtext> </blist> <blist> <bibtext> Moore L.D., Le T., Fan G. DNA Methylation and Its Basic Function. Neuropsychopharmacology. 2013; 38: 23-38. 10.1038/npp.2012.112</bibtext> </blist> <blist> <bibtext> Bonfiglio J.J., Inda C., Refojo D., Holsboer F., Arzt E., Silberstein S. The Corticotropin-Releasing Hormone Network and the Hypothalamic-Pituitary-Adrenal Axis: Molecular and Cellular Mechanisms Involved. Neuroendocrinology. 2011; 94: 12-20. 10.1159/000328226. 21576930</bibtext> </blist> <blist> <bibtext> Kang C., Shi J., Gong Y., Wei J., Zhang M., Ding H., Wang K., Yu Y., Wang S., Han J. Interaction between FKBP5 polymorphisms and childhood trauma on depressive symptoms in Chinese adolescents: The moderating role of resilience. J. Affect. Disord. 2020; 266: 143-150. 10.1016/j.jad.2020.01.051</bibtext> </blist> <blist> <bibtext> Yehuda R., Daskalakis N.P., Bierer L.M., Bader H.N., Klengel T., Holsboer F., Binder E.B. Holocaust Exposure Induced Intergenerational Effects on FKBP5 Methylation. Biol. Psychiatry. 2016; 80: 372-380. 10.1016/j.biopsych.2015.08.005</bibtext> </blist> <blist> <bibtext> Roy B., Shelton R.C., Dwivedi Y. DNA methylation and expression of stress related genes in PBMC of MDD patients with and without serious suicidal ideation. J. Psychiatr. Res. 2017; 89: 115-124. 10.1016/j.jpsychires.2017.02.005</bibtext> </blist> <blist> <bibtext> Labonte B., Yerko V., Gross J., Mechawar N., Meaney M.J., Szyf M., Turecki G. Differential Glucocorticoid Receptor Exon 1B, 1C, and 1H Expression and Methylation in Suicide Completers with a History of Childhood Abuse. Biol. Psychiatry. 2012; 72: 41-48. 10.1016/j.biopsych.2012.01.034</bibtext> </blist> <blist> <bibtext> McGowan P.O., Sasaki A., D'Alessio A.C., Dymov S., Labonté B., Szyf M., Turecki G., Meaney M.J. Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat. Neurosci. 2009; 12: 342-348. 10.1038/nn.2270</bibtext> </blist> <blist> <bibtext> Sadeh N., Wolf E.J., Logue M.W., Hayes J.P., Stone A., Griffin L.M., Schichman A.S., Miller M.W. Epigenetic variation at ska2 predicts suicide phenotypes and internalizing psychopathology. Depress. Anxiety. 2016; 33: 308-315. 10.1002/da.22480. 27038412</bibtext> </blist> <blist> <bibtext> Jokinen J., Boström A.E., Dadfar A., Ciuculete D.M., Chatzittofis A., Åsberg M., Schiöth H.B. Epigenetic Changes in the CRH Gene are Related to Severity of Suicide Attempt and a General Psychiatric Risk Score in Adolescents. Ebiomedicine. 2018; 27: 123-133. 10.1016/j.ebiom.2017.12.018. 29277323</bibtext> </blist> <blist> <bibtext> Kaminsky Z., Wilcox H.C., Eaton W.W., Van Eck K., Kilaru V., Jovanovic T., Klengel T., Bradley B., Binder E.B., Ressler K.J. Epigenetic and genetic variation at SKA2 predict suicidal behavior and post-traumatic stress disorder. Transl. Psychiatry. 2015; 5: e627. 10.1038/tp.2015.105. 26305478</bibtext> </blist> <blist> <bibtext> Currier D., Mann J.J. Stress, Genes and the Biology of Suicidal Behavior. Psychiatr. Clin. North Am. 2008; 31: 247-269. 10.1016/j.psc.2008.01.005</bibtext> </blist> <blist> <bibtext> Goto R., Okubo Y., Skokauskas N. Reasons and trends in youth's suicide rates during the COVID-19 pandemic. Lancet Reg. Heal. West. Pac. 2022; 27: 100567. 10.1016/j.lanwpc.2022.100567</bibtext> </blist> <blist> <bibtext> Thau L., Gandhi J., Sharma S. Physiology, Cortisol; StatPearls Publishing LLC.: Treasure Island, FL, USA. 2022</bibtext> </blist> <blist> <bibtext> Jiang S., Postovit L., Cattaneo A., Binder E.B., Aitchison K.J. Epigenetic Modifications in Stress Response Genes Associated With Childhood Trauma. Front. Psychiatry. 2019; 10: 808. 10.3389/fpsyt.2019.00808</bibtext> </blist> <blist> <bibtext> Penner-Goeke S., Binder E.B. Epigenetics and depression. Dialog. Clin. Neurosci. 2019; 21: 397-405. 10.31887/DCNS.2019.21.4/ebinder</bibtext> </blist> <blist> <bibtext> Herman J.P., McKlveen J.M., Ghosal S., Kopp B., Wulsin A., Makinson R., Scheimann J., Myers B. Regulation of the hypothalamic-pituitary-adrenocortical stress response. Compr. Physiol. 2016; 6: 603-621. 10.1002/cphy.c150015</bibtext> </blist> <blist> <bibtext> Austin M.C., Janosky J.E., Murphy H.A. Increased corticotropin-releasing hormone immunoreactivity in monoamine-containing pontine nuclei of depressed suicide men. Mol. Psychiatry. 2003; 8: 324-332. 10.1038/sj.mp.4001250</bibtext> </blist> <blist> <bibtext> Binder E.B. The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders. Psychoneuroendocrinology. 2009; 34: S186-S195. 10.1016/j.psyneuen.2009.05.021</bibtext> </blist> <blist> <bibtext> O'Leary J.C. III, Dharia S., Blair L.J., Brady S., Johnson A.G., Peters M., Cheung-Flynn J., Cox M.B., De Erausquin G., Weeber E.J. A New Anti-Depressive Strategy for the Elderly: Ablation of FKBP5/FKBP. PLoS ONE. 2011; 6e24840. 10.1371/journal.pone.0024840. 21935478</bibtext> </blist> <blist> <bibtext> Charmandari E., Kino T., Chrousos G.P. Glucocorticoid Receptor. Encyclopedia of Endocrine DiseasesMartini L. ; Elsevier: New York, NY, USA. 2004: 229-234</bibtext> </blist> <blist> <bibtext> Kalin N.H. Corticotropin-Releasing Hormone Binding Protein: Stress, Psychopathology, and Antidepressant Treatment Response. Am. J. Psychiatry. 2018; 175: 204-206. 10.1176/appi.ajp.2018.18010059. 29490496</bibtext> </blist> <blist> <bibtext> Xie M., Bu Y. SKA2/FAM33A: A novel gene implicated in cell cycle, tumorigenesis, and psychiatric disorders. Genes Dis. 2019; 6: 25-30. 10.1016/j.gendis.2018.11.001. 30906829</bibtext> </blist> <blist> <bibtext> Rice L., Waters E.C., Eccles J., Garside H., Sommer P., Kay P., Blackhall F.H., Zeef L., Telfer B., Stratford I. Identification and functional analysis of SKA2 interaction with the glucocorticoid receptor. J. Endocrinol. 2008; 198: 499-509. 10.1677/JOE-08-0019</bibtext> </blist> <blist> <bibtext> Pandey G.N., Rizavi H.S., Zhang H., Bhaumik R., Ren X. The Expression of the Suicide-Associated Gene SKA2 Is Decreased in the Prefrontal Cortex of Suicide Victims but Not of Nonsuicidal Patients. Int. J. Neuropsychopharmacol. 2016; 19: pyw015. 10.1093/ijnp/pyw015</bibtext> </blist> <blist> <bibtext> Hernández-Díaz Y., González-Castro T.B., Tovilla-Zárate C.A., Juárez-Rojop I.E., López-Narváez M.L., Pérez-Hernández N., Rodríguez-Pérez J.M., Genis-Mendoza A.D. Association between polymorphisms of FKBP5 gene and suicide attempt in a Mexican population: A case-control study. Brain Res. Bull. 2021; 166: 37-43. 10.1016/j.brainresbull.2020.11.002</bibtext> </blist> <blist> <bibtext> Steinberg L.J., Mann J.J. Abnormal stress responsiveness and suicidal behavior: A risk phenotype. Biomarkers Neuropsychiatry. 2020; 2: 100011. 10.1016/j.bionps.2020.100011</bibtext> </blist> <blist> <bibtext> Gupta G., Deval R., Rai N., Nizamuddin S., Upadhyay S., Pasupuleti N., Ng H.K.T., Singh P.K., Rao V.R. Genome-wide association study for suicide in high–risk isolated historical population from north east India. J. Affect. Disord. Rep. 2022; 8: 100327. 10.1016/j.jadr.2022.100327</bibtext> </blist> <blist> <bibtext> Monson E.T., Pirooznia M., Parla J., Kramer M., Goes F.S., Gaine M.E., Gaynor S.C., de Klerk K., Jancic D., Karchin R. Assessment of Whole-Exome Sequence Data in Attempted Suicide within a Bipolar Disorder Cohort. Complex Psychiatry. 2017; 3: 1-11. 10.1159/000454773</bibtext> </blist> <blist> <bibtext> Cheung S., Woo J., Maes M.S., Zai C.C. Suicide epigenetics, a review of recent progress. J. Affect. Disord. 2020; 265: 423-438. 10.1016/j.jad.2020.01.040</bibtext> </blist> <blist> <bibtext> Mirkovic B., Laurent C., Podlipski M.-A., Frebourg T., Cohen D., Gerardin P. Genetic Association Studies of Suicidal Behavior: A Review of the Past 10 Years, Progress, Limitations, and Future Directions. Front. Psychiatry. 2016; 7: 158. 10.3389/fpsyt.2016.00158. 27721799</bibtext> </blist> <blist> <bibtext> Dwivedi Y. Frontiers in Neuroscience Genetic Factors and Suicidal Behavior. The Neurobiological Basis of Suicide; Taylor & Francis Group, LLC.: Boca Raton, FL, USA. 2012</bibtext> </blist> <blist> <bibtext> Chistiakov D.A., Chekhonin V.P. Early-life adversity-induced long-term epigenetic programming associated with early onset of chronic physical aggression: Studies in humans and animals. World J. Biol. Psychiatry. 2019; 20: 258-277. 10.1080/15622975.2017.1322714. 28441915</bibtext> </blist> </ref> <aug> <p>By Diana María Dionisio-García; Alma Delia Genis-Mendoza; Thelma Beatriz González-Castro; Carlos Alfonso Tovilla-Zárate; Isela Esther Juarez-Rojop; María Lilia López-Narváez; Yazmín Hernández-Díaz; Humberto Nicolini and Viridiana Olvera-Hernández</p> <p>Reported by Author; Author; Author; Author; Author; Author; Author; Author; Author</p> </aug> <nolink nlid="nl1" bibid="bib10" firstref="ref9"></nolink> <nolink nlid="nl2" bibid="bib11" firstref="ref11"></nolink> <nolink nlid="nl3" bibid="bib13" firstref="ref12"></nolink> <nolink nlid="nl4" bibid="bib14" firstref="ref13"></nolink> <nolink nlid="nl5" bibid="bib15" firstref="ref14"></nolink> <nolink nlid="nl6" bibid="bib16" firstref="ref15"></nolink> <nolink nlid="nl7" bibid="bib17" firstref="ref16"></nolink> <nolink nlid="nl8" bibid="bib18" firstref="ref18"></nolink> <nolink nlid="nl9" bibid="bib19" firstref="ref19"></nolink> <nolink nlid="nl10" bibid="bib20" firstref="ref20"></nolink> <nolink nlid="nl11" bibid="bib12" firstref="ref28"></nolink> <nolink nlid="nl12" bibid="bib21" firstref="ref38"></nolink> <nolink nlid="nl13" bibid="bib23" firstref="ref40"></nolink> <nolink nlid="nl14" bibid="bib25" firstref="ref41"></nolink> <nolink nlid="nl15" bibid="bib24" firstref="ref46"></nolink> <nolink nlid="nl16" bibid="bib22" firstref="ref50"></nolink> <nolink nlid="nl17" bibid="bib26" firstref="ref68"></nolink> <nolink nlid="nl18" bibid="bib28" firstref="ref69"></nolink> <nolink nlid="nl19" bibid="bib29" firstref="ref70"></nolink> <nolink nlid="nl20" bibid="bib31" firstref="ref71"></nolink> <nolink nlid="nl21" bibid="bib32" firstref="ref73"></nolink> <nolink nlid="nl22" bibid="bib33" firstref="ref74"></nolink> <nolink nlid="nl23" bibid="bib34" firstref="ref77"></nolink> <nolink nlid="nl24" bibid="bib35" firstref="ref78"></nolink> <nolink nlid="nl25" bibid="bib36" firstref="ref80"></nolink> <nolink nlid="nl26" bibid="bib37" firstref="ref83"></nolink> <nolink nlid="nl27" bibid="bib38" firstref="ref84"></nolink> <nolink nlid="nl28" bibid="bib39" firstref="ref85"></nolink> <nolink nlid="nl29" bibid="bib40" firstref="ref88"></nolink> <nolink nlid="nl30" bibid="bib41" firstref="ref90"></nolink> <nolink nlid="nl31" bibid="bib42" firstref="ref91"></nolink> <nolink nlid="nl32" bibid="bib44" firstref="ref92"></nolink> <nolink nlid="nl33" bibid="bib45" firstref="ref93"></nolink> <nolink nlid="nl34" bibid="bib47" firstref="ref94"></nolink>
CustomLinks:
  – Url: https://resolver.ebsco.com/c/xy5jbn/result?sid=EBSCO:edsdoj&genre=article&issn=20763425&ISBN=&volume=13&issue=4&date=20230301&spage=584&pages=584-584&title=Brain Sciences&atitle=DNA%20Methylation%20of%20Genes%20Involved%20in%20the%20HPA%20Axis%20in%20Presence%20of%20Suicide%20Behavior%3A%20A%20Systematic%20Review&aulast=Diana%20Mar%C3%ADa%20Dionisio-Garc%C3%ADa&id=DOI:10.3390/brainsci13040584
    Name: Full Text Finder (for New FTF UI) (s8985755)
    Category: fullText
    Text: Find It @ SCU Libraries
    MouseOverText: Find It @ SCU Libraries
  – Url: https://doaj.org/article/1c7294124ab2461bac6c1e812f022d12
    Name: EDS - DOAJ (s8985755)
    Category: fullText
    Text: View record from DOAJ
    MouseOverText: View record from DOAJ
Header DbId: edsdoj
DbLabel: Directory of Open Access Journals
An: edsdoj.1c7294124ab2461bac6c1e812f022d12
RelevancyScore: 936
AccessLevel: 3
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 936.003051757813
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: DNA Methylation of Genes Involved in the HPA Axis in Presence of Suicide Behavior: A Systematic Review
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Diana+María+Dionisio-García%22">Diana María Dionisio-García</searchLink><br /><searchLink fieldCode="AR" term="%22Alma+Delia+Genis-Mendoza%22">Alma Delia Genis-Mendoza</searchLink><br /><searchLink fieldCode="AR" term="%22Thelma+Beatriz+González-Castro%22">Thelma Beatriz González-Castro</searchLink><br /><searchLink fieldCode="AR" term="%22Carlos+Alfonso+Tovilla-Zárate%22">Carlos Alfonso Tovilla-Zárate</searchLink><br /><searchLink fieldCode="AR" term="%22Isela+Esther+Juarez-Rojop%22">Isela Esther Juarez-Rojop</searchLink><br /><searchLink fieldCode="AR" term="%22María+Lilia+López-Narváez%22">María Lilia López-Narváez</searchLink><br /><searchLink fieldCode="AR" term="%22Yazmín+Hernández-Díaz%22">Yazmín Hernández-Díaz</searchLink><br /><searchLink fieldCode="AR" term="%22Humberto+Nicolini%22">Humberto Nicolini</searchLink><br /><searchLink fieldCode="AR" term="%22Viridiana+Olvera-Hernández%22">Viridiana Olvera-Hernández</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: Brain Sciences, Vol 13, Iss 4, p 584 (2023)
– Name: Publisher
  Label: Publisher Information
  Group: PubInfo
  Data: MDPI AG, 2023.
– Name: DatePubCY
  Label: Publication Year
  Group: Date
  Data: 2023
– Name: Subset
  Label: Collection
  Group: HoldingsInfo
  Data: LCC:Neurosciences. Biological psychiatry. Neuropsychiatry
– Name: Subject
  Label: Subject Terms
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22DNA+methylation%22">DNA methylation</searchLink><br /><searchLink fieldCode="DE" term="%22HPA+axis%22">HPA axis</searchLink><br /><searchLink fieldCode="DE" term="%22epigenetic%22">epigenetic</searchLink><br /><searchLink fieldCode="DE" term="%22suicide+behavior%22">suicide behavior</searchLink><br /><searchLink fieldCode="DE" term="%22stress%22">stress</searchLink><br /><searchLink fieldCode="DE" term="%22Neurosciences%2E+Biological+psychiatry%2E+Neuropsychiatry%22">Neurosciences. Biological psychiatry. Neuropsychiatry</searchLink><br /><searchLink fieldCode="DE" term="%22RC321-571%22">RC321-571</searchLink>
– Name: Abstract
  Label: Description
  Group: Ab
  Data: DNA methylation in genes of the hypothalamic–pituitary–adrenal (HPA) axis has been associated with suicide behavior. Through a systematic review, we aimed to evaluate DNA methylation levels of the genes involved in the HPA pathway and their association with suicide behavior. A search of articles was performed using PubMed and Science Direct, EBSCO. The terms included were “DNA methylation”, “suicide”, “epigenetics”, “HPA axis” and “suicide behavior”. This systematic review was performed by the Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA) statement. Six studies comprising 743 cases and 761 controls were included in this systematic review. The studies included individuals with suicide ideation, suicide attempts or completed suicide and childhood trauma, post-traumatic stress disorder (PTSD), or depression. One study reported hypermethylation in GR in childhood trauma, while two studies found hypermethylation of NR3C1 in childhood trauma and major depressive disorder (MDD). Only one study reported hypermethylation in BNDF in people with MDD. FKBP5 was found to be hypermethylated in people with MDD. Another study reported hypermethylation in CRHBP. SKA2 was reported to be hypermethylated in one study and another study found hypomethylated both in populations with PTSD. CRHR1 was found to be hypermethylated in people with MDD, and the last study found hypomethylation in CRH. Our result showed that patients with suicidal behavior showed a DNA methylation state of genes of the HPA axis in association with psychiatric comorbidity and with adverse events. Genes of the HPA axis could play a role in suicidal behavior associated with adverse events and pathologies. As a result, DNA methylation levels, proteins, and genes involved in the HPA axis could be considered for the search for biomarkers for the prevention of suicidal behavior in future studies.
– Name: TypeDocument
  Label: Document Type
  Group: TypDoc
  Data: article
– Name: Format
  Label: File Description
  Group: SrcInfo
  Data: electronic resource
– Name: Language
  Label: Language
  Group: Lang
  Data: English
– Name: ISSN
  Label: ISSN
  Group: ISSN
  Data: 2076-3425
– Name: NoteTitleSource
  Label: Relation
  Group: SrcInfo
  Data: https://www.mdpi.com/2076-3425/13/4/584; https://doaj.org/toc/2076-3425
– Name: DOI
  Label: DOI
  Group: ID
  Data: 10.3390/brainsci13040584
– Name: URL
  Label: Access URL
  Group: URL
  Data: <link linkTarget="URL" linkTerm="https://doaj.org/article/1c7294124ab2461bac6c1e812f022d12" linkWindow="_blank">https://doaj.org/article/1c7294124ab2461bac6c1e812f022d12</link>
– Name: AN
  Label: Accession Number
  Group: ID
  Data: edsdoj.1c7294124ab2461bac6c1e812f022d12
PLink https://login.libproxy.scu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.1c7294124ab2461bac6c1e812f022d12
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3390/brainsci13040584
    Languages:
      – Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 1
        StartPage: 584
    Subjects:
      – SubjectFull: DNA methylation
        Type: general
      – SubjectFull: HPA axis
        Type: general
      – SubjectFull: epigenetic
        Type: general
      – SubjectFull: suicide behavior
        Type: general
      – SubjectFull: stress
        Type: general
      – SubjectFull: Neurosciences. Biological psychiatry. Neuropsychiatry
        Type: general
      – SubjectFull: RC321-571
        Type: general
    Titles:
      – TitleFull: DNA Methylation of Genes Involved in the HPA Axis in Presence of Suicide Behavior: A Systematic Review
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Diana María Dionisio-García
      – PersonEntity:
          Name:
            NameFull: Alma Delia Genis-Mendoza
      – PersonEntity:
          Name:
            NameFull: Thelma Beatriz González-Castro
      – PersonEntity:
          Name:
            NameFull: Carlos Alfonso Tovilla-Zárate
      – PersonEntity:
          Name:
            NameFull: Isela Esther Juarez-Rojop
      – PersonEntity:
          Name:
            NameFull: María Lilia López-Narváez
      – PersonEntity:
          Name:
            NameFull: Yazmín Hernández-Díaz
      – PersonEntity:
          Name:
            NameFull: Humberto Nicolini
      – PersonEntity:
          Name:
            NameFull: Viridiana Olvera-Hernández
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-print
              Value: 20763425
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Brain Sciences
              Type: main
ResultId 1